Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Soft Tissue Sarcoma (STS)”

88 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 88 results

Testing effectiveness (Phase 2)Looking for participantsNCT05926700
What this trial is testing

Efficacy and Safety of Cadonilimab Plus Anlotinib in Advanced STS That Failed the Previous First-line Standard Treatment

Who this might be right for
Soft Tissue Sarcoma
Second Affiliated Hospital, School of Medicine, Zhejiang University 27
Large-scale testing (Phase 3)Active Not RecruitingNCT02565498
What this trial is testing

Preoperative vs Postoperative IMRT for Extremity/Truncal STS

Who this might be right for
Adult Soft Tissue Sarcoma
Mount Sinai Hospital, Canada 210
Large-scale testing (Phase 3)Study completedNCT02451943
What this trial is testing

Doxorubicin Plus Olaratumab (LY3012207) in Participants With Advanced or Metastatic Soft Tissue Sarcoma

Who this might be right for
Soft Tissue Sarcoma
Eli Lilly and Company 509
Not applicableLooking for participantsNCT02910895
What this trial is testing

A Platform of Patient Derived Xenografts (PDX) and 2D/3D Cell Cultures of Soft Tissue Sarcomas (STS)

Who this might be right for
Soft Tissue SarcomaXenograft Model2D/3D Cell Cultures
The Netherlands Cancer Institute 40
Testing effectiveness (Phase 2)Study completedNCT02549937
What this trial is testing

A Multi-Center, Open-Label Study of Surufatinib (HMPL-012) in Patients With Advanced Solid Tumors

Who this might be right for
Tumors
Hutchmed 130
Testing effectiveness (Phase 2)Looking for participantsNCT06815666
What this trial is testing

BAL Fluid Biomarkers in Sarcoma

Who this might be right for
Soft Tissue Sarcoma (STS)Bronchoalveolar Lavage (BAL)Bronchoalveolar Lavage Fluid
University Health Network, Toronto 70
Testing effectiveness (Phase 2)WithdrawnNCT06116578
What this trial is testing

Study Evaluating Pembrolizumab +/- Olaparib in TLS Positive Selected Resectable STS Followed by Adjuvant Pembrolizumab

Who this might be right for
Cancer
Gustave Roussy, Cancer Campus, Grand Paris
Very early researchLooking for participantsNCT06645808
What this trial is testing

PET-imaging of Two Vartumabs in Patients With Solid Tumors

Who this might be right for
Solid TumorColon CarcinomaRectal Carcinoma+11 more
Var2 Pharmaceuticals 32
Not applicableUnknownNCT05739084
What this trial is testing

Gene Signatures Searching of Sensitivity/Resistance to Neoadjuvant Radiotherapy in Patients With Resectable STS

Who this might be right for
Soft Tissue Sarcomas
Centre Leon Berard 300
Not applicableActive Not RecruitingNCT05776667
What this trial is testing

Feasibility Trial of Preoperative 5-Day Hypofractionated Radiotherapy for Primary Soft Tissue Sarcoma

Who this might be right for
Soft Tissue Sarcoma
Medical University of South Carolina 16
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07342322
What this trial is testing

A Prospective, Multicenter, Open-label, Single-arm Phase II Clinical Study Evaluating the Efficacy and Safety of Spatially Fractionated Radiotherapy Combined With the PraG Strategy for the Treatment of Soft Tissue Sarcoma

Who this might be right for
Soft Tissue Sarcoma (STS)
First Affiliated Hospital of Guangxi Medical University 25
Early research (Phase 1)Study completedNCT00276302
What this trial is testing

Safety Study of IPI-504 in Patients With Gastrointestinal Stromal Tumors (GIST) or Soft Tissue Sarcomas (STS)

Who this might be right for
Gastrointestinal Stromal TumorsSoft Tissue Sarcomas
Infinity Pharmaceuticals, Inc. 63
Not applicableNot Yet RecruitingNCT07401355
What this trial is testing

Improved Management of Soft Tissue Sarcomas Patients With an Optimized and Innovative Sorting Technology for Circulating Tumor Cells

Who this might be right for
Diagnosis of Soft Tissue Sarcoma (STS)
Centre Leon Berard 100
Testing effectiveness (Phase 2)Looking for participantsNCT03138161
What this trial is testing

SAINT:Trabectedin, Ipilimumab and Nivolumab for Previously Treated Advanced Soft Tissue Sarcoma

Who this might be right for
Advanced Soft Tissue SarcomaMetastatic Soft Tissue Sarcoma
Sarcoma Oncology Research Center, LLC 250
Very early researchStudy completedNCT06273852
What this trial is testing

The Intratumoral Microdose Administration of PBA-0405 in Patients With Solid Tumors

Who this might be right for
Head and Neck Squamous Cell CarcinomaSoft Tissue Sarcoma AdultTriple Negative Breast Cancer
Pure Biologics S.A. 8
Testing effectiveness (Phase 2)Study completedNCT04887298
What this trial is testing

Study of Liposomal Annamycin for the Treatment of Subjects with Soft-Tissue Sarcomas (STS) with Pulmonary Metastases

Who this might be right for
Sarcoma,Soft TissuePulmonary Metastasis
Moleculin Biotech, Inc. 36
Testing effectiveness (Phase 2)UnknownNCT05518526
What this trial is testing

Phase 1b/2 Study of Liposomal Annamycin (L-Annamycin) in Subjects With Previously Treated Soft-Tissue Sarcomas (STS) With Pulmonary Metastases

Who this might be right for
Soft Tissue SarcomaPulmonary Metastasis
Maria Sklodowska-Curie National Research Institute of Oncology 64
Large-scale testing (Phase 3)Looking for participantsNCT05597917
What this trial is testing

TTF-NGR Randomized Study - STS

Who this might be right for
Soft Tissue Sarcoma
Universität Münster 126
Testing effectiveness (Phase 2)Looking for participantsNCT07049848
What this trial is testing

SATURN-STS: Phase II Study of Neoadjuvant Atezolizumab With Doxorubicin, Concurrent Atezolizumab With Pre-operative Radiation Therapy and Adjuvant Atezolizumab in Patients With High-risk Surgically Resectable Extremity and Truncal Soft Tissue Sarcoma

Who this might be right for
Soft Tissue Sarcoma
M.D. Anderson Cancer Center 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07205185
What this trial is testing

A Multicenter, Single-arm, Prospective Phase II Clinical Study of Epalrotokewali Combined With Eribulin, Anlotinib, and Radiotherapy for the Treatment of Patients With Advanced Soft Tissue Sarcoma.

Who this might be right for
Soft Tissue Sarcoma (STS)
Fudan University 46
Load More Results